MFOHome About Commentary Discussions Funds The Best Resources Support Us!

Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Sign In Register

Categories

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.

    Support MFO

  • Donate through PayPal

John Waggoner: GMO Favors Emerging Markets Value Stocks

TedTed
in The Bullpen
FYI: (Click On Article Title At Top Of Google Search)

If the U.S. stock market seems overvalued to you, some prominent analysts are recommending a low-cost alternative — emerging markets stocks.

If that seems like lighting a damp Yule log with jet fuel, consider this: The price-to-earnings multiple on emerging markets stocks in February 2016 was lower than it was at the bottom of the 2009 stock market bottom. And earlier this year, U.S. stock market valuations were 120% higher than emerging markets stocks.
Regards,
Ted
https://www.google.com/search?source=hp&ei=0Ho7WqDmAs7D_QaisICgCw&q=investment+news+GMO+favors+emerging+markets+value+stocks&oq=investment+news+GMO+favors+emerging+markets+value+stocks&gs_l=psy-ab.3...2228.9845.0.11091.17.13.0.4.4.0.89.921.13.13.0....0...1c.1j2.64.psy-ab..0.16.848...0j0i131k1.0.TqzV0pR6TKA
Sign In or Register to comment.